These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10993101)

  • 21. Cyclooxygenase-2 expression, Ki-67 labeling index, and perifocal neovascularization in endometriotic lesions.
    Horn LC; Hentschel B; Meinel A; Alexander H; Leo C
    Ann Diagn Pathol; 2009 Dec; 13(6):373-7. PubMed ID: 19917472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of compound ezhu powder on serum levels of CA125 and CA19-9, and the expression of cyclin D protein in endometriosis patients].
    Wei M; Cao BL; Liu Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):926-30. PubMed ID: 25223174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential markers that complement expression of CA125 in epithelial ovarian cancer.
    Rosen DG; Wang L; Atkinson JN; Yu Y; Lu KH; Diamandis EP; Hellstrom I; Mok SC; Liu J; Bast RC
    Gynecol Oncol; 2005 Nov; 99(2):267-77. PubMed ID: 16061277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian strumal carcinoid with markedly high serum levels of tumor markers.
    Takemori M; Nishimura R; Sugimura K; Obayashi C; Yasuda D
    Gynecol Oncol; 1995 Aug; 58(2):266-9. PubMed ID: 7622118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum CA19-9 levels in testicular germ cell tumor patients].
    Suzuki K; Tokue A
    Hinyokika Kiyo; 2001 Jul; 47(7):467-72. PubMed ID: 11523129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of mucin-specific monoclonal antibodies and lectins in the detection of tumor-associated serum markers in gynecological cancer.
    Devine PL; McGuckin MA; Ramm LE; Harada H; Ward BG
    Cancer Biochem Biophys; 1993 Sep; 13(4):221-38. PubMed ID: 8521372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD44s, vascular endothelial growth factor, matrix metalloproteinase-2 and Ki-67 in peritoneal, rectovaginal and ovarian endometriosis.
    Kim HO; Yang KM; Kang IS; Koong MK; Kim HS; Zhang X; Kim I
    J Reprod Med; 2007 Mar; 52(3):207-13. PubMed ID: 17465288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of CA19-9 versus CA125 for the diagnosis of endometriosis.
    Harada T; Kubota T; Aso T
    Fertil Steril; 2002 Oct; 78(4):733-9. PubMed ID: 12372448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The value of serum CA125 assays in the diagnosis of uterine adenomyosis].
    Zhou Y; Wu B; Li H
    Zhonghua Fu Chan Ke Za Zhi; 1996 Oct; 31(10):590-3. PubMed ID: 9275451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The sensitivity of the CA125 immunoradiometric assay for patients with epithelial ovarian cancer and its correlation with complex treatment].
    Shi W; Zhang YJ; Jiang CY
    Zhonghua Fu Chan Ke Za Zhi; 1994 Oct; 29(10):604-6, 637-8. PubMed ID: 7712875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
    Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
    Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of tumor markers as predictors of prognosis in gastric cancer.
    Mihmanli M; Dilege E; Demir U; Coskun H; Eroglu T; Uysalol MD
    Hepatogastroenterology; 2004; 51(59):1544-7. PubMed ID: 15362797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary sequestration presenting elevated CA19-9 and CA125 with ovarian cysts.
    Komatsu H; Mizuguchi S; Izumi N; Inoue H; Oka H; Suehiro S; Nishiyama N
    Ann Thorac Cardiovasc Surg; 2014; 20 Suppl():686-8. PubMed ID: 24583704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic colorectal adenocarcinoma involving the ovary with elevated serum CA125: a potential diagnostic pitfall.
    Lewis MR; Euscher ED; Deavers MT; Silva EG; Malpica A
    Gynecol Oncol; 2007 May; 105(2):395-8. PubMed ID: 17335881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical values of CA19-9, CA125 and CEA in malignant obstructive jaundice.
    Ng WW; Tong KJ; Tam TN; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Jun; 55(6):438-46. PubMed ID: 7634181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
    Grotowski M; Maruszyński M; Piechota W
    Pol Merkur Lekarski; 2001 Dec; 11(66):476-9. PubMed ID: 11899841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Value of tumor markers in diagnosing and monitoring colorectal cancer and strategies for further improvement: analysis of 130 cases.
    Chen C; Chen LQ; Yang GL; Li Y
    Ai Zheng; 2007 Nov; 26(11):1221-6. PubMed ID: 17991322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reference intervals for carcinoembryonic antigen (CEA), CA125, MUC1, Alfa-foeto-protein (AFP), neuron-specific enolase (NSE) and CA19.9 from the NORIP study.
    Bjerner J; Høgetveit A; Wold Akselberg K; Vangsnes K; Paus E; Bjøro T; Børmer OP; Nustad K
    Scand J Clin Lab Invest; 2008; 68(8):703-13. PubMed ID: 18609108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum tumor marker CA19-9 in the follow-up of patients with cystic echinococcosis.
    Yuksel BC; Yildiz Y; Ozturk B; Berkem H; Katman U; Ozel H; Hengirmen S
    Am J Surg; 2008 Apr; 195(4):452-6. PubMed ID: 18083135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.